VIVORYON THERAPEUTICS N.V. (NL00150002Q7) — research page

NL · nl-cm-kg/XAMS/NL00150002Q7 · as of 2026-11-11

Identity and listing

The issuer is VIVORYON THERAPEUTICS N.V., listed on Euronext Amsterdam under ticker NL00150002Q7, with ISIN NL00150002Q7 and LEI 3912004AMB0KGZXZYJ15. Its security type is Corporate and its jurisdiction is Netherlands (KVK-registered). The segment is not on the record, and the sector is not on the record, as there is no sector on the FIRDS record and no machine-readable register activity code. The issuer is listed and not halted.

The disclosure read

The record holds 42 filings in the window from 2025-11-11 to 2026-11-11, across 26 filing days. The median gap between filing days is 9 days. The latest filing is dated 2026-11-07 and is of type results, 4 days before the record date of 2026-11-11. The exchange median cadence gap is 10.2 days across 123 issuers, the median filings count is 15, and the median latency is 7.0 days. The issuer's 42 filings are above the exchange median of 15 filings. The sector peer comparison is not on the record for this market. Filings by type are: 17 results, 15 newswire releases, 5 directors' dealings, 3 ad hoc, and 2 AGM/EGM.

window 2025-11-11 to 2026-11-11 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record. The record carries the annual report link only, as a source link and not a read. The auditor's location and any auditor changes are not on the record, as this register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is clear: the issuer is listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category under the rule version acm-68000/nl/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.

rule acm-68000/nl/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's own investor-relations page, count 0.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The vintage of this market is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)

10.2

https://api.gleif.org/api/v1/lei-records/3912004AMB0KGZXZYJ15 (identity.jurisdiction)

10.3

https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)

10.4

https://mcp.nl-cm-kg.ai/events/XAMS/NL00150002Q7 (the disclosure lines)

10.5

https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)

10.6

https://mcp.nl-cm-kg.ai/book/aio.json (the orderability chapter)

10.7

https://mcp.nl-cm-kg.ai/record/XAMS/NL00150002Q7 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"NL00150002Q7"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:7897318f2126e6e5.